Your browser doesn't support javascript.
loading
CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete Remission.
Kharfan-Dabaja, Mohamed A; Labopin, Myriam; Bazarbachi, Ali; Salmenniemi, Urpu; Mielke, Stephan; Chevallier, Patrice; Thérèse Rubio, Marie; Balsat, Marie; Pioltelli, Pietro; Menard, Anne-Lise; Socié, Gerard; Huynh, Anne; Schaap, Nicolaas; Bermúdez Rodríguez, Arancha; Cornelissen, Jan J; Yakoub-Agha, Ibrahim; Aljurf, Mahmoud; Giebel, Sebastian; Brissot, Eolia; Peric, Zina; Nagler, Arnon; Mohty, Mohamad.
Afiliación
  • Kharfan-Dabaja MA; Dvision of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
  • Labopin M; Sorbonne University, Department of Hematology, Hôpital Saint Antoine and INSERM UMRs 938, Paris, France.
  • Bazarbachi A; Blood and Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut, Lebanon.
  • Salmenniemi U; HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland.
  • Mielke S; Karolinska Institute and University Hospital, Department of Laboratory Medicine, CAST, Stockholm, Sweden.
  • Chevallier P; CHU Nantes, Department D'Hématologie, Nantes, France.
  • Thérèse Rubio M; CHRU BRABOIS, Service Hématologie, Vandoeuvre Nancy, France.
  • Balsat M; Centre Hospitalier Lyon Sud, Service Hematologie, Lyon, France.
  • Pioltelli P; Ospedale San Gerardo, Clinica Ematologica dell`Universita Milano-Biocca, Monza, Italy.
  • Menard AL; Centre Henri Becquerel, Hematology, Rouen, France.
  • Socié G; Hopital St. Louis, Department of Hematology - BMT, Paris, France.
  • Huynh A; CHU, Institut Universitaire du Cancer Toulouse, Oncopole, Toulouse, France.
  • Schaap N; Radboud University Medical Centre, Department of Hematology, Nijmegen, The Netherlands.
  • Bermúdez Rodríguez A; Hospital U. Marqués de Valdecilla, Servicio de Hematología-Hemoterapia c/ Marqués de Valdecilla s/n, Santander, Spain.
  • Cornelissen JJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Yakoub-Agha I; CHU de Lille LIRIC, Univ Lille, INSERM U1286, France.
  • Aljurf M; King Faisal Specialist Hospital & Research Centre, Oncology (Section of Adult Haematolgy/BMT), Riyadh, Saudi Arabia.
  • Giebel S; Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Brissot E; Sorbonne University, Department of Hematology, Hôpital Saint Antoine and INSERM UMRs 938, Paris, France.
  • Peric Z; University Hospital Centre Zagreb and School of Medicine, University of Zagreb, Croatia.
  • Nagler A; Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
  • Mohty M; Acute Leukemia Working Party of EBMT, Paris, France.
Hemasphere ; 6(11): e788, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36258923
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Idioma: En Revista: Hemasphere Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Idioma: En Revista: Hemasphere Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos